chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2-26 to 4-8-2021:  Bad headaches (front/ sinus area) to mild, to 24/7, to intermittent. Sl Nausea. Chills. Muscle aches. Fatigue. Watery eyes/ congestion. Stiff/ sore neck. Out of it. Mid April to present.  Burning/ Buzzing Bilateral feet and hands --- 24/7.  8-1 to present Bruised feet (heels, balls) sensation. Long Covid ?  Covid infection in March ?   PT.  Also, concussion 4-16-2021. Advil, diazepam, hydrocodone
Thu night serious chest pain, burning, up through neck into jaw. Thought it was the worst heartburn I'd ever had possibly a heart attack.  Super bad for a week. Went urgent care finally.  Better now but still an issue. Lightheaded, burning, weakness in thighs, circulation bad. Accidentally found myocarditis and that describes it. After bad reaction to first,  much worse than covid was, I probably shouldn't have gotten it. I'm worried it won't heal. I want CDC to know so another like me can make an informed decision.  I'm totally pro vax so I don't tell people online.  I called after first vax for 2 weeks and requested the forms and they wouldn't take the info or send forms.
left brachial neuritis; nausea; fever; This is a literature report.  A 29-year-old male patient received COVID-19 Vaccine - Manufacturer Unknown, as dose 2, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Mrna sars-cov2 (Dose 1 Single, left arm), for covid-19 immunization, reaction(s): "mild pain at the injection site". The following information was reported: RADICULITIS BRACHIAL (medically significant), outcome "recovering", described as "left brachial neuritis"; NAUSEA (medically significant), outcome "unknown"; PYREXIA (medically significant), outcome "unknown", described as "fever". The patient underwent the following laboratory tests and procedures: Electromyogram: left brachial neuritis. Therapeutic measures were taken as a result of radiculitis brachial.  Clinical course: 29 year-old male received his firstmRNA SARS-CoV-2 n his left arm. He had isolated persistent mild pain at the injection site. This prompted him to receive his second vaccine in his right arm three weeks later. Within a few hours of the injection, he had fever, nausea, and severe pain near his left tricep and olecranon process. The severe pain improved somewhat after treatment with opiates. In the next two weeks, he developed left arm weakness, numbness in his left fourth and fifth digits, with eventual muscle wasting of his left trapezius. The weakness was profound and prevented him from performing activities of daily living. An EMG confirmed the diagnosis of left brachial neuritis. He was treated with oral steroids, physical therapy, and improved within several months with residual mild paresthesias. He received the influenza vaccine approximately six months later in his right arm. The exact symptoms returned in his left arm, though milder, and self-resolved after a week.; Sender's Comments: Based on the available information in the case, an association between the reported events RADICULITIS BRACHIAL ,NAUSEA, PYREXIA  and The suspected drug cannot be ruled out.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-PV202300089693 Same article/suspect/patient and different event;
Red, slightly swollen at site of injection, occurring approximately 18 hours of injection.  24-30 hour slight itch.  Disappeared in 42 hours.
Daughter received chickenpox vaccine on the 15 of June this year. On Saturday June 23, she developed a fever, with a rash on her face. Sunday June 24, the rash began to spread over her body, with what looks like the beginning of chickenpox. Fever has continued, and rash is spreading. She went to her pediatrician June 25, and the doctor also believes it can be a section the vacation.
Swollen and closing Throat, Swollen And Numbed Lips And Tongue.; Swollen and closing Throat, Swollen And Numbed Lips And Tongue.; Swollen and closing Throat, Swollen And Numbed Lips And Tongue.; Swollen and closing Throat, Swollen And Numbed Lips And Tongue.; Swollen and closing Throat, Swollen And Numbed Lips And Tongue.; Swollen and closing Throat, Swollen And Numbed Lips And Tongue.; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 05Mar2021 11:00 (at 52 years old, not pregnant) Batch/Lot Number: EN6204) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included High blood pressure, High lipids, KNown allergies:penicillin, all from an unknown date. No concomitant medications. On 05Mar2021, patient experienced swollen and closing throat, swollen and numbed lips and tongue. Treatment for events was Benadryl. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. No covid prior vaccination. Covid tested post vaccination. The patient underwent lab tests and procedures which included Nasal Swab sars-cov-2 test: negative on 21Mar2021. Facility type vaccine: available. No other vaccine in four weeks. The outcome of the events was Resolved with Sequel.  No follow-up attempts are needed. No further information is expected.
I felt fine after the injection. 3-4 days later I feel like I got a cold. Very achy and tired. Probably has nothing to do with the vaccination but I wear 2 masks and go out very infrequently. I?m very careful. If it?s a cold I must have gotten it at the hospital.
autoimmune issues: continually sick with colds [viral and bacterial] recurring swelling of lips, face and tongue most recently on December 16.
20 mins p/ receiving 3rd dose of Hep B vax, pt stated felt weak, dizzy & legs felt like rubber; BP 136/80 pulse 64; sl SOB; hands became numb & tingling; taken to hosp;
Post vaccination inmate reports feeling dizzy w/headache; BP 150/ 65 P82;  minimal  improvement post medical monitoring x 30 min,    continues to c/o dizziness and headache, Inmate transported to hospital for further evaluation/ treatment.
This spontaneous report as received from a medical assistant refers to a identifiable patient. The patient's medical history and concurrent medications were not reported. On 08-MAR-2018 the patient was inadvertently vaccinated with expired dose of VARIVAX (lot # M006157 expiration date 05-FEB-2018), by subcutaneous route for prophylaxis (expired product administered). Concomitant therapies included sterile diluent (DILUENT MRK INJ). There was no temperature excursion involved. No adverse effects were reported. No additional information provided.
covid arm; red; hot; itchy; Covid arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), VACCINATION SITE REACTION (covid arm), ERYTHEMA (red), FEELING HOT (hot) and PRURITUS (itchy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE REACTION (Covid arm). On 17-Mar-2021, the patient experienced VACCINATION SITE REACTION (covid arm), ERYTHEMA (red), FEELING HOT (hot) and PRURITUS (itchy). At the time of the report, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE REACTION (covid arm), ERYTHEMA (red), FEELING HOT (hot) and PRURITUS (itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication included antihistamine.    Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Outcome of events was updated(changed from unknown to resolved).
While receiving TDAP adult booster vaccine, felt the needle aim too high up into shoulder.  Felt a rupture in shoulder towards the end of the injection.  Immediate onset of severe pain, inability to lift right arm.  Severe, tearing pain has persisted for 5 days so far.  Unable to lift arm, attend work or sleep due to unbearable pain.  Contacted the administering nurse practitioner.  Have not heard back yet for treatment options.
severe muscle pain surrounding injection site; inflammation; fever; minor hives; nausea; fatigue; Severe muscle pain surrounding injection site; This is a spontaneous report from a contactable consumer, the patient. A 24-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the  left arm on 13Apr2021 at 16:45 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, stomach upset and major depressive disorder. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and chlorhexidine towelette (MANUFACTURER UNKNOWN)  on an unspecified date for an unknown indication and experienced drug allergy. The patient had no known allergies to medications, food or other products. Concomitant medications included drospirenone (MANUFACTURER UNKNOWN) from 13Apr2021 at 16:45 and ethinylestradiol (MANUFACTURER UNKNOWN).  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 the patient experienced severe muscle pain surrounding injection site, inflammation, mild fever, minor hives surrounding injection site, nausea, and fatigue all within 2 days of receiving the vaccine. Hives developed 2 days later, muscle pain receding. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the adverse events. The clinical outcome of the event severe muscle pain surrounding injection site, inflammation, fever, minor hives, nausea and fatigue was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This is day 12 after  the vaccination. I noticed a large rash 5?x 2 1/2? on left arm about 1/2? below injection site. First time I had noticed it?no pain or itching.  Have not contacted MD yet. Will be watching it.   Can I have 2nd shot in same arm?  I am 23 year right side breast cancer survivor and have always used left arm for shots, etc.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via media via a company representative concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. On an unspecified date, the patient was previously treated with 2 doses of covid-19 vaccine from unspecified manufacturer (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported, (dose number in series was 1), administered for prophylactic vaccination. It was unknown whether patient had any adverse events (Dose number in series was 1). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose, (Dose number in series was 2) start therapy date were not reported administered 1 in total  for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced suspected clinical vaccination failure, and suspected covid-19 infection (Dose number in series was 2) "we had different brand but 2 plus Booster and still got Covid Variant But Dr. said would be much worse , if not had vaccine but was still very sick. Thank God for the vaccine". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000217076.; Sender's Comments: V0:20220227500-COVID-19 VACCINE AD26.COV2.S-suspected clinical vaccination failure. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Arm became sore around 6pm & painful during the night. 12-10-2009 the patient came to pharmacy & got pharmacist told him to go see a doctor. Patient did get Rx for antibiotic-DOXYCYCLINE 160mg twice a day for 7 days by Friday infection had spread. Saturday AM went back to doctor & doctor admitted him to hospital. Patient was on IV antibiotic for 2 days. he was released on 12-14-2009.
Patient with flight abroad.  Acute Abdominal pain.  Treated-inflammation-all blood tests and US normal. Released-abdominal pain improved.
Patient came in for a flu vaccine together with the covid vaccine. I gave him two covid vaccine instead.
On Saturday evening, began feeling achy, had chills and sweats, felt feverish. Did not take temperature. Right arm was sore soon after injection. However on Saturday, right arm at injection site was red, swollen and hot to the touch.
Rash formed on the back side of my right thigh probably 4-6 hours after receiving vaccine. Rash has intensified over time. One week after receiving the first dose, the area of the rash increased in size, turned darker in color, and the skin became more inflamed and sensitive.
Fatigue, chills, fever, muscle soreness, and joint pain all over for 24 hours, starting 24 hours after second injection. Laying down was painful due to serve joint and muscle pain in my neck and arms in the last 8 hours. I sat or stood to relieve the neck pain. I took 2 ibuprofen at 9am Saturday to help with the pain. I had fully recovered by 1pm Saturday, the 8th.
Headache, Myalgia, Arthralgia, Chills,Fatigue Narrative:
Right arm had moderate edema, erythema extending from deltoid to elbow. Treated with Benadryl IM.
This spontaneous report as received from a other health professional refers to a patient of unknown age.  On an unknown date the patient was vaccinated with VARIVAX for prophylaxis. On an unknown date the patient experienced incorrect product storage and poor quality drug administered. The outcome of poor quality drug administered is unknown.   The reporter considered incorrect product storage and poor quality drug administered to be not related to VARIVAX.  Sender's Comments: US-009507513-1707USA001044: US-009507513-1707USA001045: US-009507513-1707USA001046:
Localized reaction; Reaction aggravated; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE REACTION (Localized reaction) and ADVERSE REACTION (Reaction aggravated) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Localized reaction) and ADVERSE REACTION (Reaction aggravated). At the time of the report, VACCINATION SITE REACTION (Localized reaction) and ADVERSE REACTION (Reaction aggravated) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.  Concomitant product use was unknown by the reporter.
pt recvd vax; rash from face to upper groin; fever; some loose stools;
Started as a constant foggy head; has steadily gotten worse.  Now the headache is occasionally so severe that he simply goes to sleep for comfort.  Cannot take car rides. Has missed several days of school.  Taking to a neurologist today.
Patient received varicella vaccine and flu vaccine; had local reaction and that night developed rash behind right knee that was itchy.
Patient reports that she has a headache or heaviness and it never goes away and reports if she moves to fast she gets dizzy. Denies fever, redness.  Started off feeling like her whole body was heavy it is only in her head now.  Has a hard time concentrating on work.  May have temporary blurry vision. Denies fevers, sob, weakness or TIA symptoms.
Within one week of receiving the Covid booster vaccination, I developed very loose stools as well as some urgency.  At first it was occasional but eventually I began having 1-3 very loose stools on a daily basis.  I had a consult with a gastroenterologist.  He thought it might be ischemic colitis, as the diarrhea often occurred following my going for a run. However, it also occurred on nonrunning days.  My GI doc felt it would be prudent to perform a colonoscopy, since it had been just over 3 years since my last colonoscopy and he wanted to obtain several colon biopsies to aid in his diagnosis.  The colonoscopy was performed on 1/25/2022, and pathological findings revealed lymphocytic colitis.  Interestingly, following the colonoscopy, my symptoms improved somewhat and I had firmer (though still loose) stools for about one week.  Then the diarrhea restarted.  I changed my diet to low fiber and continued my usual low fat diet, and currently my symptoms are somewhat improved again (as of approximately 3/7/2022).  Also, my gastroenterologist wanted to prescribe budesonide as a treatment for the colitis, but my ophthalmologist cautioned against this due to a possible increase in eye pressure with a corticosteroid.  Thus I have not yet used any type of medication to treat the condition.
R09.02 HYPOXEMIA 5/3/2023 BILAT CAROTID ARTERY STENOSIS R09.02 HYPOXEMIA 5/3/2023 GANGRENE R09.02 HYPOXEMIA 5/3/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Patient vaccinated with Pfizer vaccine mixed with sterile water instead of 09% Normal Saline, preservative free. Consulted with Agencies to determine next steps for patient after discovery. Re-vaccination advised and outreach team contacting impacted patient and offering to speak with a physician to discuss.
Itching, swollen tongue.  Prescribed famotidine 20, and banophen 25.
two days after receiving the vaccine, the pt began to throw up all day. Her heart was also beating so fast she decided to call an ambulance and go to the hospital where she received fluids
muscle soreness; Felt warm all the time; This case was reported by a other health professional via call center representative and described the occurrence of muscle soreness in a 73-year-old female patient who received Herpes zoster (Shingrix) (batch number 3LL4P, expiry date 19th October 2021) and (batch number KH3CZ, expiry date 5th December 2021) for prophylaxis.   On 25th October 2019, the patient received the 1st dose of Shingrix. On an unknown date, the dose was an unknown dose. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced muscle soreness and feeling of warmth. On an unknown date, the outcome of the muscle soreness and feeling of warmth were unknown.   It was unknown if the reporter considered the muscle soreness and feeling of warmth to be related to Shingrix.  Additional details were provided as follows: The patient that after receiving the first dose of Shingrinx and experienced muscle soreness and felt warm all the time.  The patient was asking about when the patient should receive the second dose. The reporter consented to follow up.  The batch number for Shingrinx was reported as 3LLP , but it was changed to 3LL4P as per sales data sheet. The batch number for Shingrinx adjuvant was reported as 4H3C2, but it was changed to KH3CZ as per sales data sheet.
flu like symptoms; 104 degree fever; body aches; nausea; head ache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 46-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Oct2021 11:00 (Lot number: FH8020) at the age of 46 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN2601, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 11Feb2021, when the patient was 46 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL9263, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM), administration date: 21Jan2021, when the patient was 46 years old, for COVID-19 Immunization. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "flu like symptoms"; PYREXIA (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "104 degree fever"; PAIN (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "body aches"; NAUSEA (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "nausea"; HEADACHE (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "head ache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of influenza like illness, pyrexia, pain, nausea, headache.  Additional information: Seriousness Criteria-Results in death was reported as no. Seriousness Criteria-Life threatening was NO. Seriousness criteria-Caused/prolonged hospitalization was as no. Seriousness Criteria-Disabling/Incapacitating was NO. Seriousness criteria-Congenital anomaly/birth defect was reported as NO. Facility where the most recent COVID-19 vaccine was administered (withheld). the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No treatment ae. No known allergies. No other medical history. Prior to vaccination, was the patient diagnosed with COVID-19 was reported as No. Since the vaccination, has the patient been tested for COVID-19 was reported as no.?  Follow-up attempts are completed. No further information is expected.
Pt called 10/2/2013 stating he received a flu vaccine and had mild soreness the day of vaccine. The next day he said he experienced burning, bruising, chest pain, back pain, etc. He reported that he did not seek medical attention. He states 12 days later that symptoms are improving.
Preexisting Conditions: None given prior Vaccination;  10:33 observed 'scissoring', seizure activity, falls out of chair, hits head, generalized tonic clonic x 30secs Post Vaccination and seizure, Attendee reports he is hung over, didn't rehydrate, nor eaten breakfast. No Seizure history prior to this event. Left with EMS to ER